Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
NEXTDC Ltd (ASX:NXT) announced plans on Monday to raise approximately A$2.2 billion through a combination of a fully underwritten A$1.5 billion accelerated entitlement offer and an expanded A$1.7 billion hybrid securities issuance. The fundraising follows a sharp jump in contracted utilisation and a sizable increase in the company's forward order b…
SK Hynix has begun large-scale manufacturing of a 192GB SOCAMM2 memory module built for Nvidia's upcoming Vera Rubin AI processor. The company says the module targets AI server workloads while reducing power consumption, and claims it will address memory bottlenecks encountered in large language model training and inference. The announcement coinci…
On April 20, National Australia Bank said it expects to record credit impairment charges of A$706 million in the first half as it raises provisions amid concerns the Middle East conflict increases the likelihood of an Australian downside economic scenario. The bank also announced an accelerated after-tax software amortisation charge of A$949 millio…
Shares of Viva Energy plunged after a fire at its Geelong refinery in Corio, Victoria interrupted processing at the gasoline complex. The blaze was contained and extinguished, but the site will operate at reduced output in the near term while a review of damage, repairs, and financial effects is carried out.
Eli Lilly is in advanced discussions to acquire private biotech Kelonia Therapeutics for more than $2 billion, according to people familiar with the talks. The deal - which could be announced as soon as Monday if negotiations hold - would bolster Lilly's oncology pipeline by adding a next-generation CAR-T candidate aimed at multiple myeloma. The tr…
U.S. stock index futures turned lower Sunday evening following a week of all-time highs on Wall Street, as a spike in U.S.-Iran tensions and reports of U.S. military action against an Iranian-flagged cargo vessel weighed on risk sentiment and pushed oil prices higher. Traders are watching developments ahead of a temporary ceasefire expiry this week…
Fiserv, Inc. will release its first quarter 2026 earnings results on May 5 before market open, followed by a webcast presentation. Furthermore, the company will hold an Investor Day on May 14 to detail its business strategy and medium-term outlook. Both events will be accessible via live webcast on the company's investor relations website.
Ascendis Pharma A/S has begun trading its ordinary shares on the Nasdaq Global Select Market under ticker ASND, replacing its previous American Depositary Shares (ADSs) listing. This follows a mandatory exchange of all outstanding ADSs for ordinary shares, completed on April 20, 2026.
Commerce's BigCommerce platform has powered Mountain Warehouse's launch of a new composable ecommerce store, replacing their decade-old system. This upgrade allows Mountain Warehouse to scale more efficiently, accelerate innovation, and improve global ecommerce operations, leveraging a flexible, modern tech stack with enhanced security and integrat…
Ardelyx, Inc., a Nasdaq-listed biopharmaceutical firm, announces the appointment of Felecia W. Ettenberg as Chief Legal Officer. Ms. Ettenberg brings over 25 years of legal expertise in the biopharmaceutical industry, most recently from Bristol Myers Squibb. She will lead Ardelyx's legal, compliance, regulatory, and government affairs functions, po…
Astec Industries, a Nasdaq-listed manufacturer specializing in equipment for road building and aggregate processing, announced the appointment of Chad Hartley as Group President of Infrastructure Solutions. Hartley brings extensive leadership experience from Regal Rexnord and Emerson Electric, and is expected to drive operational improvements and c…
Fulcrum Therapeutics, a clinical-stage biopharmaceutical company focused on rare hematological disorders, will release its Q1 2026 financial results on April 27, 2026, prior to market open. Management will hold a conference call and webcast at 8:00 a.m. ET to discuss the results and corporate updates, including progress on their lead program, pocir…
Amneal Pharmaceuticals announced encouraging interim data from its ongoing Phase 4 ELEVATE-PD study evaluating CREXONT®, an extended-release carbidopa/levodopa formulation for Parkinson's disease. Among 111 patients switching from existing therapies such as IR CD/LD and RYTARY®, CREXONT significantly increased daily 'Good On' time by approximately …
Abacus Global Management, a NYSE-listed alternative asset management company, announced its participation in the 2026 Milken Institute Global Conference. The company's CEO will discuss key trends impacting private wealth, including aging populations, the great wealth transfer, and AI's role in financial advice. Abacus management will also engage in…
Phathom Pharmaceuticals announced it will report its Q1 2026 financial results and provide a business update via a live webcast on April 30, 2026. The company focuses on developing and commercializing novel gastrointestinal disease treatments, including its marketed product VOQUEZNA for GERD and H. pylori infection treatment in the U.S.
LENZ Therapeutics has submitted a Marketing Authorization Application to the UK's MHRA for VIZZ®, an FDA-approved aceclidine-based eye drop for presbyopia treatment. This marks the sixth regulatory submission outside the US as LENZ advances international commercialization efforts following positive Phase 3 trial results and early US market launch.
Beyond Air's subsidiary, Beyond Cancer, presented updated Phase 1 clinical data for its investigational immunotherapy UNO at AACR 2026, reporting prolonged survival in heavily pretreated cancer patients after a single intratumoral injection. The trial included patients with breast cancer, squamous cell carcinoma, and melanoma, many of whom had exha…
Allogene Therapeutics presented new scientific data and advancements at the AACR 2026 Annual Meeting, emphasizing the potential of their allogeneic CAR T cell therapies to provide off-the-shelf, scalable, and accessible treatment options for cancer and autoimmune diseases. The company showcased dual-targeting technology and expanded their pipeline,…
Fortuna Mining Corp., a Canadian precious metals miner listed on the NYSE and TSX, has entered into an earn-in agreement with Qstone Inc. to acquire up to a 70% interest in the Quartzstone Project, a 29,600-hectare land package in Guyana's highly prospective gold-rich greenstone belt. Historical drilling reveals multiple zones of high-grade near-su…
BlackRock Asset Management Canada, a subsidiary of BlackRock, Inc., announced the cash distributions payable in April 2026 for various iShares exchange-traded funds listed on the TSX and Cboe Canada, including both bond and equity ETFs. The distributions apply to unitholders of record as of April 27, 2026, with payments on April 30, 2026. Distribut…
Silvaco Group, Inc. announced a strategic partnership with Taiwan's Industrial Technology Research Institute (ITRI) to deploy Silvaco's SmartSpice circuit simulation solution within ITRI's Nankang IC Design Incubation Center. This collaboration aims to support advanced microcontroller unit (MCU) development and accelerate startup innovation in semi…
Super League Enterprise, Inc. announced a shareholder letter encouraging support for its acquisition of the Misfits Ads Division. The acquisition is expected to add profitable revenue, improve financial predictability, expand market share, and speed the company's path to sustainable cash-based EBITDA profitability. The transaction diversifies reven…
Immuneering Corporation presented new genetic data at the AACR Annual Meeting demonstrating that their MEK inhibitor, atebimetinib, rarely induces common resistance mutations in the MAPK pathway in treated patients. This supports the drug's potential for durable tumor shrinkage and improved survival in first-line pancreatic cancer. The company is a…
Inspired Entertainment, a US-listed provider of B2B gaming content and systems, has launched its premium iGaming portfolio in South Africa through partnerships with key local operators like Hollywood Bets and Betway. Enabled by its agreement with Light & Wonder, this move marks a significant expansion into a growing and regulated South African iGam…
FreightCar America, a leading North American manufacturer of railroad freight cars and related services, announced it will release its Q1 2026 financial results on May 4, 2026, followed by a teleconference on May 5 to discuss the results. The company specializes in the production, repair, and conversion of freight railcars, emphasizing their role i…
